Home > Boards > US Listed > Biotechs > Calithera Biosciences, Inc. (CALA)

Next week presentation on Keystone symposia:

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Sikmarson Member Profile
 
Followed By 2
Posts 81
Boards Moderated 0
Alias Born 06/23/14
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/19/2019 4:55:19 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/19/2019 4:51:07 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/19/2019 4:07:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/19/2019 4:06:00 PM
Calithera Biosciences, Inc. Prices Public Offering of 12,500,000 shares of Common Stock GlobeNewswire Inc. - 6/18/2019 11:00:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/17/2019 5:02:51 PM
Calithera Biosciences, Inc. Announces Commencement of Underwritten Public Offering of Common Stock GlobeNewswire Inc. - 6/17/2019 4:01:00 PM
Calithera Achieves Positive Topline Results in Randomized Phase 2 ENTRATA Study of Telaglenastat with Everolimus in Renal Cel... GlobeNewswire Inc. - 6/17/2019 6:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/3/2019 4:09:58 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2019 4:09:55 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2019 4:09:24 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2019 4:07:58 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2019 4:07:44 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2019 4:07:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2019 4:07:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2019 4:06:49 PM
Biotechs That Successfully Combat Cancer Could See Blockbuster Returns NetworkNewsWire - 5/29/2019 8:45:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/24/2019 4:07:22 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 5/10/2019 1:21:06 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/9/2019 5:07:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/9/2019 4:56:00 PM
Calithera Biosciences Reports First Quarter 2019 Financial Results and Recent Highlights  GlobeNewswire Inc. - 5/9/2019 4:06:00 PM
Calithera Biosciences to Report First Quarter 2019 Financial Results on Thursday, May 9, 2019 GlobeNewswire Inc. - 5/3/2019 7:05:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/17/2019 4:07:07 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/5/2019 4:13:37 PM
Sikmarson   Thursday, 03/02/17 05:29:27 AM
Re: None
Post # of 188 
Next week presentation on Keystone symposia:

THURSDAY, MARCH 9

Ethan Emberley, Calithera Biosciences, USA
Short Talk: CB-839, a Selective Glutaminase Inhibitor, has Anti-Tumor Activity in Renal Cell Carcinoma and Synergizes with Everolimus and Cabozantinib

program



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist